[Phenotypes of leukemic cells from chronic B cell leukemia and their proliferative responses to several kinds of mitogens or lymphokines: PHA or phorbol ester (TPA) induces a high responsibility to B cell growth factor (BCGF) in the leukemic cells].
Takeuchi
H
H
D000328:Adult; D000368:Aged; D002455:Cell Division; D004357:Drug Synergism; D005260:Female; D006801:Humans; D015847:Interleukin-4; D007378:Interleukins / Q000494:pharmacology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000473:pathology*; D008222:Lymphokines / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology*; D010641:Phenotype; D010835:Phytohemagglutinins / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000473:pathology
D007378:Interleukins; D008222:Lymphokines; D008934:Mitogens; D010835:Phytohemagglutinins; C028784:phytohemagglutinin-P; D015847:Interleukin-4; D013755:Tetradecanoylphorbol Acetate